Forodesine hydrochloride: Phase I preliminary data

Preliminary data from an open-label, dose-escalating Phase I trial in

Read the full 105 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE